Opinion

Sow

Court
District Court, E.D. Pennsylvania
Filed
Apr 10, 2026
Cited by
0 cases
Authority
More cited than 41.2%

The opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

KAREN SOW,

Plaintiff,

CIVIL ACTION

v. NO. 26-1223

COMBE INCORPORATED, et al.,

Defendants.

Pappert, J. April 10, 2026

MEMORANDUM

On February 5, 2026, Karen Sow sued Combe Inc., Pennsylvania CVS Pharmacy,

LLC and a John Doe Corporation in the Philadelphia County Court of Common Pleas,

alleging state law claims of negligence, strict products liability and breach of warranty.

(Am. Compl, Dkt. No. 1, Ex. A at 23–30.) She purportedly bought and applied a

defective product called “Just 5 Hair Dye,” which she claims caused severe injuries to

her scalp. (Id. ¶¶ 14–23.) Combe removed the case to this Court on February 25,

asserting Sow’s state law product liability claims raise substantial federal questions.

(Not. of Removal ¶ 6, Dkt. No. 1 at 3–4.) Sow now moves to remand the case to state

court, arguing removal was improper because her claims arise exclusively under state

law. (Mot. to Remand at 6–7, Dkt. No 7.) The Court grants the motion.

I

A defendant in state court can remove a case if the federal court would have

original jurisdiction over it. 28 U.S.C. § 1441(a). District courts must remand a case to

state court if removal was improper because of a procedural defect or because the

district court lacks subject matter jurisdiction. 28 U.S.C. § 1447(c). “The removal

statutes are to be strictly construed against removal and all doubts should be resolved

in favor of remand.” Boyer v. Snap-on Tools Corp., 913 F.2d 108, 111 (3d Cir. 1990)

(internal quotation marks omitted). Combe bears the burden to show removal is

proper. Dukes v. U.S. Healthcare, Inc., 57 F.3d 350, 359 (3d Cir. 1995).

If, as here, the parties are nondiverse, removal is proper only if the case arises

under federal law. U.S. Express Lines Ltd. v. Higgins, 281 F.3d 383, 389 (3d Cir. 2002).

Whether it does usually “turns on the well-pleaded complaint rule.” Aetna Health Inc.

v. Davila, 542 U.S. 200, 207 (2004) (quoting Franchise Tax Bd. of California v. Constr.

Labs. Vacation Trust for S. California, 463 U.S. 1, 9–10 (1983)). Under this rule, a

defendant generally cannot remove a case “unless the plaintiff’s complaint establishes

that the case ‘arises under’ federal law.” Id. (quoting Franchise Tax Bd., 463 U.S. at

10). Sow is the “master of [her complaint]” and “she may avoid federal jurisdiction by

exclusive reliance on state law.” Caterpillar Inc. v. Williams, 482 U.S. 386, 392 (1987).

II

Combe argues Sow’s state law claims arise under federal law because they raise

“substantial federal questions.” (Not. of Removal ¶¶ 6 & 8.) “[E]ven where a claim

finds its origins in state rather than federal law,” it may nonetheless arise under

federal law in “a special and small category of cases.” Gunn v. Minton, 568 U.S. 251,

258 (2013) (citation and internal quotation marks omitted). To do so, the federal issue

must be: “(1) necessarily raised, (2) actually disputed, (3) substantial, and (4) capable of

resolution in federal court without disrupting the federal-state balance approved by

Congress.” Id. (citing Grable & Sons Metal Prods., Inc. v. Darue Engineering & Mfg.,

545 U.S. 308, 314 (2005)).

In its notice of removal, Combe argues the Food, Drug, and Cosmetic Act and its

regulations govern the “sufficiency” of their product’s “labeling and warnings.” (Not. of

Removal ¶¶ 15 & 16) (citing 21 C.F.R. § 701; 21 U.S.C. § 361.) Combe attempts to

characterize Sow’s complaint as an attack on federal law: “Plaintiff’s allegations

amount to alleging that federal regulations themselves are inadequate and

insufficient[]” and this “alleged inadequacy and insufficiency of federal law, by

necessity, implicates [a] substantial federal question.” (Resp. in Opp’n at 5, Dkt. No.

10.)

Combe’s reference to a federal regulatory scheme does not establish federal

question jurisdiction. First, “it takes more than an implication of a federal element to

raise a state-law cause of action to a substantial federal issue.” Brown v. Rite Aid

Corp., 415 F. Supp. 3d 588, 593–94 (E.D. Pa. 2019) (citation omitted). And, although

Combe may refer to federal laws and regulations to defend Sow’s state law claims, “a

case may not be removed to federal court on the basis of a federal defense, including the

defense of preemption, even if the defense is anticipated in the plaintiff’s complaint,

and even if both parties concede that the federal defense is the only question truly at

issue.” Briones v. Bon Secours Health Sys., 69 F. App’x. 530, 534 (3d Cir. 2003) (quoting

Caterpillar, 482 U.S. 393.) “Simply put, ‘state-law tort and products liability claims

regarding [products] regulated by the FDA . . . do not give rise to federal question

jurisdiction.’” Brown, 415 F. Supp. 3d at 594 (quoting Burrell v. Bayer Corp., 918 F.3d

372, 380 (4th Cir. 2019)).

Combe fails to carry its burden to show the Court has jurisdiction over Sow’s

claims. The Court will remand the case to state court pursuant to 28 U.S.C. § 1447(c).1

III

Sow argues she is entitled to attorneys’ fees and costs under 28 U.S.C. 1447(c).

(Mot. to Remand at 11, Dkt. No. 7.) “[A]bsent unusual circumstances, attorney’s fees

should not be awarded when the removing party has an objectively reasonable basis for

removal.” Martin v. Franklin Capital Corp., 546 U.S. 132, 136 (2005). This rule

“recognize[s] the desire to deter removals sought for the purpose of prolonging litigation

and imposing costs on the opposing party, while not undermining Congress’ basic

decision to afford defendants a right to remove as a general matter.” Id. at 140. The

Court has “broad discretion and may be flexible in determining whether to require the

payment of fees.” Mints v. Educ. Testing Service, 99 F.3d 1253, 1260 (3d Cir. 1996).

This can be a complicated area of the law, see Gunn, 568 U.S. at 258, and the

Court cannot say all of Combe’s removal arguments were objectively unreasonable or

that it sought removal to prolong litigation or impose costs on the opposing party.

An appropriate Order follows.

BY THE COURT:

_/s_/_ G__e_r_a__ld__ J__. _P_a__p_p_e rt

Gerald J. Pappert, J.

1 Combe also contends Sow’s state law claims are completely preempted by federal law. (Not.

of Removal ¶ 6.) Under the doctrine of complete preemption, removal may be proper if “the

[Supreme] Court has concluded that the pre-emptive force of a statute is so ‘extraordinary’ that it

‘converts an ordinary state common-law complaint into one stating a federal claim for purposes of

the well-pleaded complaint rule.’” Kline v. Security Guards, Inc., 386 F.3d 246, 252 (3d Cir. 2004)

(quoting Caterpillar, 482 U.S. at 393.) But “[n]o court has held that the federal FDCA completely

preempts a plaintiff’s recovery action for purposes of removal jurisdiction.” Pennsylvania Emps.

Benefit Tr. Fund v. Eli Lilly & Co., No. 07-2057, 2007 WL 2916195, at *4 (E.D. Pa. Oct. 5, 2007). In

any event, Combe seems to abandon this argument and does not mention it in its response.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.